MedPath
NMPA Approval

Mirabegron Sustained-release Tablets

国药准字H20253035

January 2, 2025

Drug Information

米拉贝隆缓释片

片剂

25mg

化学药品

January 2, 2025

Company Information

Applicant Company

重庆市渝中区长江二路12号第三层

Manufacturing Company

广州市黄埔区瑞祥路228号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

米拉贝隆缓释片 - NMPA 批准文号 | MedPath